Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy
Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy is a paper indexed in PICO Portal from OpenAlex.
How many citations does Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy have?
Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy has 149 citations in the OpenAlex counts PICO Portal stores.
When was Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy published?
Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy has 2021 year in the PICO Portal index.
What is the open-access status of Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy?
Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy has gold oa status in the PICO Portal index.
What is the DOI of Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy?
The DOI for Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy is on the source record.
What is the PMID of Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy?
The PMID for Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy is on the source record.
What is the OpenAlex record for Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy?
The OpenAlex for Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy is on the source record.